Navigation Links
Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
Date:9/18/2012

AARHUS, Denmark, September 18, 2012 /PRNewswire/ --

Which embryos have the best opportunity to develop into a viable pregnancy? A new technology provides a surprising answer.

A major challenge in the field of IVF is selecting the single best embryo which is likely to result in a live birth. Currently, embryologists must remove the embryo from a standard incubator to perform 2 or 3 short evaluations of the developing embryo under the microscope, at fixed time-points over 3-5 days, in order to assess embryo quality prior to transferring an embryo to the patient. 

     (Photo: http://photos.prnewswire.com/prnh/20120918/562489 )

The EmbryoScope® Time-lapse system generates a movie allowing embryologists to monitor various characteristics of the embryo development over the entire incubation period, while maintaining optimum incubation conditions in a state-of-the-art incubator.

According to breakthrough scientific results, embryos which exhibit irregular division patterns have a much lower pregnancy potential. The results were made available online on August 27 in the journal Fertility & Sterility, and confirms the benefits of implementing the EmbryoScope® Time-lapse system from the Danish company Unisense FertiliTech A/S.

A clinical multi-center study from Equipo IVI, Spain, Maigaard clinic and Brædstrup Hospital in Denmark, including a total of 5225 embryos, reports significantly reduced implantation of embryos which have a second division cycle occurring in less than 5 hours (considered direct cleavage), compared  to the implantation probability of "normally" developing embryos. The embryos with a short second division cycle will simply not have enough time for DNA replication, which is a prerequisite for a normal cell division.

Nearly 14% of all examined embryos exhibited this division pattern and according to the study will have a greatly reduced probability of resulting in a viable pregnancy. For both patients and fertility clinics it is important to decrease transfer of embryos with low very low implantation potential. With this new technology, clinics now have objective criteria with which to identify the embryo with a higher chance of implanting allowing more successful single embryo transfer cycles.

Marcos Meseguer, co-author of the paper and senior embryologist at Equipo IVI in Valencia, states "The ability to identify abnormal development events in embryos is certainly a key advantage of using time-lapse systems such as the Embryoscope® allowing us to improve our patient treatment".

The improvement potential of implementing time-lapse systems is increasing constantly as scientists discover new information about early human embryo development and more than 180 IVF clinics are using the Embryoscope® technology worldwide.

About Unisense FertiliTech A/S:

Unisense FertiliTech A/S was founded in 2003 to develop technology to improve human embryo assessment in assisted reproduction. Unisense FertiliTech has developed, and manufactures the EmbryoScope®- a unique Time-lapse system facilitating improved IVF treatment, flexible work routines and effective communication through comprehensive documentation of embryo development and evolving improvements in selection. The System is FDA 510(k) cleared and CE marked as a Class II medical device.

Our Mission is to help infertile couples achieve their dream of parenthood through development of novel technology, quantification and digitized documentation. "The Vision to Conceive"

For further information please contact:
CEO, Jens Gundersen
Email: jkg@fertilitech.com

COO, Søren Ankerstjerne
Email: sa@fertilitech.com

+45(0)89449500

Unisense FertiliTech A/S

http://www.fertilitech.com



'/>"/>
SOURCE Unisense FertiliTech A/S
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States
2. Caliber IDs VivaScope technology found to be 100% sensitive for basal cell carcinoma diagnosis
3. Pomona Valley Hospital is First in the Region to Use Innovative Technology for Neonates
4. Medisafe 1 Technologies Anticipates a Special Dividend of $0.01 (One Cent) to Each Shareholder of One Common Stock pending the $7MM Perpetual License Sale of Technology Rights
5. Vibrant Research Founder Dr. Pratheev Sreetharan Recipient of the TR35 Award from Technology Review Magazine
6. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
7. Global Markets for Membrane Technology for Pharmaceuticals
8. Agricultural Biotechnology: Emerging Technologies and Global Markets
9. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
10. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
11. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. ... a federal institution supporting research in Germany ... and patient treatments at the University Clinic Heidelberg as ... The MRIdian Linac program will be headed by ... also heads radiation oncology at the German Cancer Research ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
(Date:1/20/2017)... ... ... to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of Christmas. ... in Oklahoma City, and a devoted woman of faith. , “Becoming a parent changes ... back of my mind for years, but actually doing it might have been a while ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):